Medical News Summary: New drug proving effective in reducing cancer cells following chemotherapy
About: New drug proving effective in reducing cancer cells following chemotherapy
Date: 7 December 2004
Source: Forbes
Medical News Summary (summary of medical news story as reported by Forbes): A new drug (GVAX) which is currently undergoing the trial process is proving that it can decrease residual cancer cells in acute myelogenous leukemia patients following chemotherapy. Trial results showed that 69% of subjects and reduced blood cancer cells and 60% had reduced bone marrow cancer cells. The drug is currently being tested for its efficacy on patients with multiple myeloma, prostate cancer, lung cancer and pancreatic cancer.
URL: http://www.forbes.com/technology/sciences/feeds/ap/2004/12/07/ap1695954.html
Related Disease Topics: Cancer, Myelogenous leukemia (type of Leukemia), Bone marrow cancer, Blood cancer, Multiple myeloma, Prostate cancer, Lung cancer, Pancreatic cancer
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Research
- research and cancer
- research and myelogenous leukemia
- Research and bone marrow cancer
- Research and blood cancer
- research and multiple myeloma
- research and prostate cancer
- research and lung cancer
- research and pancreatic cancer
- Medication
- medication and cancer
- medication and myelogenous leukemia
- Medication and bone marrow cancer
- Medication and blood cancer
- medication and multiple myeloma
- medication and prostate cancer
- medication and lung cancer
- medication and pancreatic cancer
- Chemotherapy
Medical Tools & Articles:
Next articles:
Medical Articles: